Form CORRESP - Correspondence:
SEC Accession No. 0001193125-21-134170
Filing Date
2021-04-27
Accepted
2021-04-27 15:47:08
Documents
1

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 6784
  Complete submission text file 0001193125-21-134170.txt   7705
Mailing Address 1030 MASSACHUSETTS AVENUE SUITE 210 CAMBRIDGE MA 02138
Business Address 1030 MASSACHUSETTS AVENUE SUITE 210 CAMBRIDGE MA 02138 617-952-0555
Werewolf Therapeutics, Inc. (Filer) CIK: 0001785530 (see all company filings)

EIN.: 823523180 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CORRESP
SIC: 2834 Pharmaceutical Preparations